Clinical trial
Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT07871760 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 22, 2027
- Completion date
- December 31, 2028
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, long term, quality of life, recurrence free